GO
Loading...
 

Tesaro: Next big thing in biotech?

Mon 13 Jan 14 | 05:45 PM ET
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

Tesaro: Next big thing in biotech?

Mon 13 Jan 14 | 05:45 PM ET
Lonnie Moulder, Tesaro CEO, discusses the drug Rolapitant, which controls the effects of chemotherapy. Moulder says it's not about market share but about accessing patients who should receive the drug.
 
RELATED ARTICLES AND CONTENT
More Videos
Go
Displaying results for: Latest Video | US